课题基金 / 基金详情

Exploration of oncogenic or tumor-suppressive microRNAs in oral cancer.

Exploration of oncogenic or tumor-suppressive microRNAs in oral cancer.
口腔癌中致癌或肿瘤抑制性 microRNA 的探索。
批准号:
18591997
负责人:
KOZAKI Ken-ichi
金额:
$2.36万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KOZAKI Ken-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the last few years, microRNAs (miRNAs) have started a revolution in molecular biology and emerged as key players in the carcinogenesis. They have been identified in various tumor types, showing that different sets of miRNAs are usually deregulated in different cancers. To identify the miRNA signature that was specific for oral squamous cell carcinoma (OSCC), we first examined expression profiles of 148 miRNAs in a panel of 18 OSCC cell lines and the immortalized oral keratinocyte line RT7 as a control. As compared with RT7, the expression of 54 miRNAs(36.5%) was frequently down-regulated in OSCC lines(< 0.5-fold expression, 〓 66.7% of 18 lines). Among these 54 miRNAs, we further analyzed four of these miRNAs. i.e., miR-34b, miR-137, miR-193a, and miR-203, located around CpG islands, to identify tumor-suppressive miRNAs silenced through aberrant DNA methylation. The expression of those four genes was restored by treatment with 5-aza-2'-deoxycytidine in OSCC cells lacking their expression. In addition, expression levels of the four miRNAs were inversely correlated with their DNA methylation status in the OSCC lines. In primary tumors of OSCC with paired normal oral mucosa, down-regulation of miRNA expression through tumor-specific hypermethylation was more frequently observed for miR-137 and miR-193a than for miR-34b and miR 203. Moreover, the ectopic transfection of miR-137 or miR-193a into OSCC lines lacking their expressions significantly reduced cell growth, with down-regulation of the translation of CDK6 or E2F6, respectively. Taken together, our results clearly demonstrate that miR-137 and miR-193a are tumor-suppressor miRNAs epigenetically silenced during oral carcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRTFDCl, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation
PRTFDCl 是一种可能的肿瘤抑制基因,在口腔鳞状细胞癌中经常因启动子异常甲基化而沉默
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [井本逸勢, 稲澤譲治]
通讯作者: 稲澤譲治
DOI: 10.1111/j.1349-7006.2006.00343.x
发表时间: 2006-12-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Kozaki, Ken-ichi, Imoto, Issei, Inazawa, Johji]
通讯作者: Inazawa, Johji
DOI: 10.1111/j.1349-7006.2007.00491.x
发表时间: 2007-07-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Kawasaki, Tsutomu, Yokoi, Sana, Inazawa, Johji]
通讯作者: Inazawa, Johji
DOI: 10.1158/0008-5472.can-07-5194
发表时间: 2008-04-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者: [Kozaki, Ken-ichi, Imoto, Issei, Inazawa, Johji]
通讯作者: Inazawa, Johji
17
    Establishment of a novel gene promoter activity detection system for cell isolation and characterization.
    • 批准号:
      26670815
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2014
    • 负责人:
      KOZAKI Ken-ichi
    • 依托单位:
    Integrated approach for identification of tumor-suppressive microRNAs and clinical application to miRNA-based therapy for cancers
    • 批准号:
      23390077
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2011
    • 负责人:
      KOZAKI Ken-ichi
    • 依托单位:
    Establishment and characterization of immortalized human ameloblastoma cell lines, HAM1 and 2
    The experimental study of specific COX-2 inhibitors applied to non-surgical therapy of postoperative recurrences and distant metastasis of lung cancer.
    • 批准号:
      11670160
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1999
    • 负责人:
      KOZAKI Ken-ichi
    • 依托单位:
    海外基金